echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Depression, blood markers of antidepressant response are confirmed

    Depression, blood markers of antidepressant response are confirmed

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Researchers led by Mark Rasenick, a well-known professor of physiology and biophysics and psychiatry at the University of Illinois at Chicago, published a new proof-of-concept study that discovered a biomarker in human platelets that can be used to track the degree of depression


    This study builds on the previous studies of several researchers.


    "When you are depressed, adenylate cyclase is very low


    The new study "A new peripheral biomarker of depression and antidepressant response" published in "Molecular Psychiatry" has identified a cellular biomarker for lipid raft Gsα translocation


    In other words, depression may be recognized through blood tests in the future


    Rasenick said: "What we have developed is a test that not only can indicate the presence of depression, but also a single biomarker that indicates treatment response, which has not yet existed


    Researchers hypothesize that they will be able to use this blood test to determine whether antidepressant treatment is effective, possibly as early as a week after starting treatment


    A blood test may be able to show whether Gsα has detached from the lipid raft after a week


    Rasenick said: "Because the platelets will change within a week, you will see the patient's condition will get better


    Currently, patients and their doctors must wait weeks, sometimes months, to determine whether antidepressants are effective, and when they are determined to be ineffective, they will try different therapies


    Rasenick said: "About 30% of people are not getting better-their depression is not alleviated


    Rasenick collaborated with his company Pax Neuroscience to develop screening tests after further research


    Steven D.




    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.